X
Four first-person video stories that highlight the daily battles against pain of patients with chronic pathology. This is the content of the mini web series released in June 2020 by Cittadinanzattiva, as part of the campaign "We are not born to suffer", promoted on the occasion of the 10th anniversary of Law 38 which regulates access to palliative care and pain therapy and which puts Italy in a vanguard position for citizens' rights.
“We were not born to suffer": this is the name of the campaign launched in May 2020 by Cittadinanzattiva, ten years after the law 38/2010 which regulates access to palliative care and pain therapy and which puts our country in a leading position for citizens' rights.
Launched on the occasion of World Anesthesia Day, the "Ready to go" project is an initiative of MSD in collaboration with Cittadinanzattiva and SARNePI (Italian Society of Anesthesia and Italian Neonatal and Pediatric Resuscitation). The goal is to raise awareness and inform people also on the subject of pediatricanesthesia and on the pain of young patients.
To support the implementation of the Pillar, and prepare the ground for the Pillar’s Action Plan (to be presented in early 2021), the Commission launched a call for pledges to implement the Pillar from European, regional and national stakeholders. Societal Impact Pain (SIP) mapped seven out of the 20 Principles of the European Pillar of Social Rights that link directly to SIP’s four priorities: indicators, education, employment, research.
To support the implementation of the Pillar, and prepare the ground for the Pillar’s Action Plan (to be presented in early 2021), the Commission launched a call for pledges to implement the Pillar from European, regional and national stakeholders. Societal Impact Pain (SIP) mapped seven out of the 20 Principles of the European Pillar of Social Rights that link directly to SIP’s four priorities: indicators, education, employment, research.
Spinal cord stimulation (SCS) has shown to be an effective therapy for various chronic pain conditions, improving the quality of life of patients, and reducing medication intake on the long term. However, some chronic pain patients can develop tolerance / habituation over time. A combination therapy can address this issue effectively in the majority of them as a research has shown.
Female-focused research is one key aspect of creating precision drugs & personalized medicine. Increasingly, data are highlighting sex differences in the mechanisms underlying chronic pain. However, most research is still conducted in males. This new research, just published, shows abnormal subgenual anterior cingulate circuitry is unique to women but not men with ankylosing spondylitis related chronic pain.
Acmella Orbacea is a herbaceous plant whose flower is traditionally used to treat oral pain. A recent study confirms the anti-inflammatory and antioxidant activities of the plant, which could therefore be a valid ally for pain management, especially in chronic degenerative diseases, but all this must necessarily be reflected in clinical studies.
Did you know that your weight can impact joint pain? If you have knee or hip pain, you may be able to help researchers understand what people with arthritis want to know from their doctors about weight management and nutrition strategies to reduce joint pain. One of the Osteoarthritis Action Alliance's goals is to develop resources for individuals with osteoarthritis (OA) that provide them with the knowledge, skills and confidence to effectively manage their symptoms. We are beginning to develop patient materials that relate to nutrition and OA management; we are seeking input from people with OA to help shape the content of these materials and the format that would be most effective for adults with OA.
The president of the Sine Dolore Association, historic spanish partner of ACN, has been selected to form part of the Board of Directors of the Pain Alliance Europe (PAE), in which is involved since many years Cittadinanzattiva trought its EU branch Active Citizenship Network.
Cittadinanzattiva APS
p.iva: 02142701008
via Imera, 2
00183 Roma
Tel: (+39) 06.36.71.81
Fax: (+39) 06.36.71.83.33
Rue Philippe Le Bon, 46
1000 Brussels - Belgium
